Tata Capital Limited has notified stock exchanges that the audio recording of its earnings conference call for the third quarter of fiscal year 2026 is now available for investors and stakeholders. The call, held on January 19, 2026, covered the company's financial performance for the quarter and nine months ended December 31, 2025.

Regulatory Compliance and Disclosure

The company made this disclosure in accordance with Regulations 30 and 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was sent to both major stock exchanges where Tata Capital is listed.

Investor Access and Availability

The audio recording has been made available on the company's official website in the investor information section. Investors and analysts can access the complete earnings discussion through the company's dedicated investor relations portal at their convenience.

Financial Results Coverage

The earnings call discussed both unaudited standalone and consolidated financial results for the reporting period. The call provided insights into the company's performance during the quarter and nine months ended December 31, 2025, offering stakeholders comprehensive information about Tata Capital's financial position and operational highlights.

Corporate Communication

The disclosure was signed by Sarita Kamath, Chief Legal and Compliance Officer & Company Secretary, ensuring proper corporate governance protocols were followed. The communication demonstrates Tata Capital's commitment to maintaining transparency with its investor community and adhering to regulatory requirements for listed companies.

Tata Capital Limited has filed its quarterly monitoring agency report with stock exchanges, showcasing efficient utilization of proceeds from its Initial Public Offering (IPO). The report, prepared by CARE Ratings Limited for the quarter ended December 31, 2025, indicates that the company has deployed 98% of its fresh issue proceeds in accordance with the stated objectives.

IPO Details and Fund Deployment

The company's IPO, conducted from October 6-8, 2025, raised a total of ₹15,512 crores, making it one of the significant public offerings in the non-banking financial services sector. The issue structure comprised two components: a fresh issue worth ₹6,846 crores and an offer for sale amounting to ₹8,666 crores.

Fund Utilization Progress

According to the monitoring agency report, the fresh issue proceeds have been systematically deployed across the planned objectives. The primary allocation was directed toward augmenting the company's Tier-1 capital to meet future capital requirements, including onward lending activities arising from business growth.

Specific Fund Deployment

The monitoring report provides detailed insights into how the Tier-1 capital augmentation funds were utilized. Out of the ₹6,697 crores allocated for this purpose, ₹5,200 crores was specifically used for repayment of borrowings, while ₹1,497 crores was deployed toward onward lending activities. This strategic allocation aligns with the company's growth objectives in the non-banking financial services sector.

Unutilized Proceeds Management

As of December 31, 2025, ₹128 crores remains unutilized, primarily consisting of pending issue expenses. The monitoring agency noted that the total estimated issue-related expenses amount to ₹326 crores, shared among Tata Sons Limited, International Finance Corporation, and Tata Capital Limited. The company's share of the closing balance stands at ₹128 crores, while ₹145 crores is attributable to the other two parties involved in the offer for sale.

Compliance and Monitoring

CARE Ratings Limited, in its capacity as the monitoring agency, confirmed that all utilization aligns with disclosures made in the offer document. The report indicates no deviations from the stated objectives, no changes in the means of finance for disclosed objects, and no major deviations from earlier monitoring reports. All necessary government and statutory approvals related to the objectives have been obtained.

Timeline Performance

The company demonstrated efficient execution by completing the Tier-1 capital augmentation objective ahead of schedule. While the offer document specified a completion date of March 31, 2026, the company achieved this milestone by October 14, 2025, indicating strong project management and execution capabilities.

The Board of Directors and Audit Committee reviewed and approved the monitoring agency report during their meetings held on January 17, 2026, and January 19, 2026, respectively, confirming that the net proceeds were utilized for purposes stated in the prospectus without any material deviations.